GO TO CMA Home
GO TO Inside CMA
GO TO Advocacy and Communications
GO TO Member Services
GO TO Publications
GO TO Professional Development
GO TO Clinical Resources

GO TO What's New
GO TO Contact CMA
GO TO Web Site Search
GO TO Web Site Map


CMAJ
CMAJ - March 23, 1999JAMC - le 23 mars 1999

Outcome of pulmonary tuberculosis treatment in the tertiary care setting — Toronto 1992/93

Table 4: Predictors of death on multivariate analysis
Variable Unadjusted odds ratio (and 95% CI) Adjusted odds ratio (and 95% CI)
Age > 30 and <= 50 yr* 2.2 (0.7–7.8) 5.1 (0.9–29.1)
Age > 50 yr* 4.3 (1.2–13.1) 16.7 (2.6–105.1)
HIV infection 5.2 (2.0–14.0) 16.1 (3.9–66.4)
Immunosuppressive therapy 7.6 (2.3–26.2) 8.0 (1.9–34.4)
Multidrug-resistant M. tuberculosis 11.5 (1.1–117.8) 30.7 (1.5–623.0)
*Reference category = age <= 30 yr.

[Return to text]